SMS Pharmaceuticals

quarterly
yearly
ParticularsSep '22Dec '22Mar '23Jun '23Sep '23
Revenue160.04151.01150.69135.85167.45
Expenses159.20144.35140.05123.17152.29
EBITDA14.1720.7224.4926.7028.63
EBIT6.0812.6116.5219.0020.73
Profit Before Tax0.846.6710.6412.6815.16
Net Profit0.735.288.078.8112.05
Financial Ratios
Operating Profit Margin8.89%13.93%16.39%19.73%17.18%
Net Profit Margin-1.26%2.53%4.16%6.90%7.04%
Earning Per Share (Diluted)-0.240.440.731.101.39
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.5.1
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ